We analyzed the expression distribution of RBCK1 in tumor and normal samples from the TCGA database and GTEx Portal and found the significantly different expression of RBCK1 in pan-cancers, such as bladder cancer, breast cancer, glioma, lung cancer, and liver cancer. This evidence concerns the gene RBCK1 and central nervous system cancer.